Sigma Planning Corp Decreases Stock Holdings in Masimo Co. (NASDAQ:MASI)

Sigma Planning Corp decreased its holdings in Masimo Co. (NASDAQ:MASI) by 11.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 2,569 shares of the medical equipment provider’s stock after selling 336 shares during the period. Sigma Planning Corp’s holdings in Masimo were worth $301,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. State of Michigan Retirement System raised its position in Masimo by 0.9% in the 4th quarter. State of Michigan Retirement System now owns 10,696 shares of the medical equipment provider’s stock worth $1,254,000 after buying an additional 100 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its position in Masimo by 140.6% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 243 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 142 shares during the last quarter. CWM LLC increased its position in shares of Masimo by 13.5% during the 4th quarter. CWM LLC now owns 1,318 shares of the medical equipment provider’s stock valued at $154,000 after purchasing an additional 157 shares during the last quarter. Byrne Asset Management LLC purchased a new stake in shares of Masimo during the 4th quarter valued at about $28,000. Finally, Buckhead Capital Management LLC increased its position in shares of Masimo by 10.0% during the 3rd quarter. Buckhead Capital Management LLC now owns 2,800 shares of the medical equipment provider’s stock valued at $246,000 after purchasing an additional 255 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Trading Up 0.7 %

Shares of NASDAQ:MASI opened at $136.14 on Friday. The stock has a 50 day moving average of $135.77 and a 200 day moving average of $116.53. The company has a market cap of $7.20 billion, a PE ratio of 90.16 and a beta of 0.97. The company has a current ratio of 2.18, a quick ratio of 1.22 and a debt-to-equity ratio of 0.64. Masimo Co. has a 12-month low of $75.22 and a 12-month high of $190.82.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.43. Masimo had a return on equity of 13.77% and a net margin of 3.98%. The business had revenue of $548.90 million during the quarter, compared to the consensus estimate of $545.69 million. During the same period in the prior year, the company posted $1.32 EPS. The firm’s revenue for the quarter was down 11.0% compared to the same quarter last year. As a group, equities research analysts expect that Masimo Co. will post 3.51 EPS for the current year.

Analyst Ratings Changes

MASI has been the subject of several research reports. Needham & Company LLC lowered shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Wells Fargo & Company raised shares of Masimo from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $117.00 to $160.00 in a research report on Monday, March 25th. Jefferies Financial Group reaffirmed a “hold” rating and set a $121.00 price target (up previously from $107.00) on shares of Masimo in a research report on Tuesday, January 30th. Stifel Nicolaus raised shares of Masimo from a “hold” rating to a “buy” rating and upped their price target for the company from $148.00 to $170.00 in a research report on Monday, April 15th. Finally, Piper Sandler upped their price target on shares of Masimo from $70.00 to $117.00 and gave the company a “neutral” rating in a research report on Monday, February 26th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, Masimo presently has an average rating of “Hold” and an average price target of $137.43.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.